Hypocholesterolemia and Statins in Multiple Myeloma
International Blood Research & Reviews,
Statins are lipid-lowering agents. They also have immunomodulatory, anti-inflammatory, anti-angiogenic, and anti-proliferative functions. In this context, they are demonstrated to have beneficial effects on mortality in several malignancies including esophageal, breast, lung, liver, pancreatic, endometrial, and colorectal cancers. Multiple myeloma is considered as an incurable plasma cell disorder with current therapy; however due to the current knowledge about the correlation between cholesterol-lowering agents and myeloma; it’s suggested to have lower mortality rates for patients using statins. Patients with multiple myeloma usually have a low cholesterol level which is often underestimated by clinicians. Hereby we aimed to summarize the myeloma-hypocholesterolemia relationship and emphasize the importance of statins as an inexpensive and beneficial approach for these patients.
- Cell line
- multiple myeloma
How to Cite
Cafforio P, Dammacco F, Gernone A, Silvestris F. Statins activate the mitochondrial pathway of apoptosis in human lymphoblasts and myeloma cells. Carcinogenesis 2005;26:883-91.
Broniarek I, Jarmuszkiewicz W. Statins and mitochondria. Postepy Biochem.2016; 62:77-84.
Sato JD, Kawamoto T, Okamoto T .Cholesterol requirement of P3-X63-Ag8 and X63-Ag8.653 mouse myeloma cells for growth in vitro. J Exp Med. 1987;165: 1761–1766
Terzi H, Altun A, Şencan M In vitro comparison of the cytotoxic effects of statins on U266 myeloma cell line. Indian J Med Res. 2019; 150:630-634.
Yavasoglu I, Tombuloglu M, Kadikoylu G, et al. Cholesterol levels in patients with multiple myeloma. Ann Hematol. 2008;7: 223-8.
Van der Spek E, Bloem AC, van de Donk NW, et al. Dose-finding study of high-dose simvastatin combined with standard chemotherapy in patients with relapsed or refractory myeloma or lymphoma. Haematologica. 2006;91:542-5.
Van der Spek E, Bloem AC, Sinnige HA, et al. High dose simvastatin does not reverse resistance to vincristine, adriamycin, and dexamethasone (VAD) in myeloma. Haematologica. 2007;92:e130- 1.
Brånvall E, Ekberg S, Eloranta S, et al. Statin use is associated with improved survival in multiple myeloma: A Swedish population-based study of 4315 patients. Am J Hematol. 2020;95: 652-661.
Kristen Marie Sanfilippo, Jesse Keller, Brian F. Gage et al. Statins Are Associated With Reduced Mortality in Multiple Myeloma. J Clin Oncol. 2016 Nov 20; 34(33): 4008–4014.
Afzal A, Fiala MA, Gage BF, Wildes TM, Sanfilippo K. Statins Reduce Mortality in Multiple Myeloma: A Population-Based US Study. Clin Lymphoma Myeloma Leuk 2020 ;20:e937-e943.
Abstract View: 111 times
PDF Download: 64 times